Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- RELOADIndependent statistical analysis of Improving Function After Knee Arthroplasty With Weight-Bearing Biofeedback: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01333189).
- REMAINIndependent statistical analysis of A Phase IV Study of Rebif ® 44mcg Administered Three Times Per Week by Subcutaneous Injection Compared With no Treatment in the Therapy of Relapsing Multiple Sclerosis After…
- REMDACTAIndependent statistical analysis of A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia: primary endpoint results, effect…
- Remicade Safety Line (Crohn’s Disease)(Study P03288)(COMPLETED): Complete Statistical AnalysisIndependent statistical analysis of Remicade Safety Line (Crohn's Disease)(Study P03288)(COMPLETED): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00818272).
- remifentanilIndependent statistical analysis of Remifentanil Only vs. Midazolam and Meperidine During Elective Colonoscopy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01693185).
- Remifentanil and Glycemic Response in Cardiac Surgery: Complete Statistical AnalysisIndependent statistical analysis of Remifentanil and Glycemic Response in Cardiac Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02349152).
- REMINDERIndependent statistical analysis of Impact Of Eplerenone On Cardiovascular Outcomes In Patients Post Myocardial Infarction: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REMINETIndependent statistical analysis of A Study Evaluating Lanreotide as Maintenance Therapy in Patients With Non-Resectable Duodeno-Pancreatic Neuroendocrine Tumors (REMINET): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- REMIT-DMIndependent statistical analysis of Remission Through Early Monitored Insulin Therapy - Duration Month: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03670641).
- REMIX-2Independent statistical analysis of A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of CSU in Adults Inadequately Controlled by H1-antihistamines: primary endpoint results, effect estimate with confidence…
- ReMMi-DIndependent statistical analysis of Study of Two Digital Therapeutics for the Prevention of Episodic Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REMODELIndependent statistical analysis of Personalized Infliximab Induction Strategy With Model-informed Dosing in Patients With Crohn's Disease: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA): Complete Statistical AnalysisIndependent statistical analysis of Remote Glucose Monitoring System in Hospitalized Patients With Diabetic Ketoacidosis (DKA): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: Complete Statistical AnalysisIndependent statistical analysis of Remote Ischemic Conditioning to Enhance Resuscitation (RICE) Pilot: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04265807).
- Remote Participation (Within USA) Trial of Sana Pain Reliever: Complete Statistical AnalysisIndependent statistical analysis of Remote Participation (Within USA) Trial of Sana Pain Reliever: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04280562).
- REMOTE-COVIDIndependent statistical analysis of Remote Monitoring Use In Cases Of Suspected COVID-19 (Coronavirus): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04337489).
- Remote-delivered MBCT for SCAD Survivors: Complete Statistical AnalysisIndependent statistical analysis of Remote-delivered MBCT for SCAD Survivors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04983680).
- REMOVALIndependent statistical analysis of REducing With MetfOrmin Vascular Adverse Lesions in Type 1 Diabetes (REMOVAL): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: Complete Statistical AnalysisIndependent statistical analysis of RENABLATE Feasibility Study CS156 (EC12-02) Study of Catheter Based Renal Denervation to Treat Resistant Hypertension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: Complete Statistical AnalysisIndependent statistical analysis of Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Renal Impairment Study of Empagliflozin (BI10773) in Japanese Patients With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.: Complete Statistical AnalysisIndependent statistical analysis of Renal Impairment Study of PF-07321332 Boosted With Ritonavir in Adult Participants With Renal Impairment and in Healthy Participants With Normal Renal Function.: primary endpoint results, effect estimate with…
- Renal Osteodystrophy: An Individual Management Approach: Complete Statistical AnalysisIndependent statistical analysis of Renal Osteodystrophy: An Individual Management Approach: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02440581).
- Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration: Complete Statistical AnalysisIndependent statistical analysis of Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: Complete Statistical AnalysisIndependent statistical analysis of Renal Transplants in Hepatitis C Negative Recipients With Nucleic Acid Positive Donors: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).: Complete Statistical AnalysisIndependent statistical analysis of Renal, Endocrine, and Bone Changes in Response to FTC/TDF in Uninfected Young Men Who Have Sex With Men (YMSM).: primary endpoint results, effect estimate with confidence interval, sample-size…
- RENEWIndependent statistical analysis of Study to Evaluate the Safety, Tolerability of BCX9930 in Participants With Either Complement 3 Glomerulopathy (C3G), Immunoglobulin A Nephropathy (IgAN), or Primary Membranous Nephropathy (PMN): primary endpoint results,…
- RENEWIndependent statistical analysis of A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combination Chemotherapy in Patients With Mantle Cell Lymphoma (MCL).: primary endpoint results, effect…
- RENEWIndependent statistical analysis of Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory Angina: primary endpoint results, effect estimate with confidence…
- RENEWIndependent statistical analysis of Lung Volume Reduction Coil Treatment in Patients With Emphysema (RENEW) Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Renin and Renal Biomarker Response to Angiotensin II: Complete Statistical AnalysisIndependent statistical analysis of Renin and Renal Biomarker Response to Angiotensin II: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04558359).
- Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer: Complete Statistical AnalysisIndependent statistical analysis of Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Reopening Schools Safely and Educating Youth Research Study (ROSSEY): Complete Statistical AnalysisIndependent statistical analysis of Reopening Schools Safely and Educating Youth Research Study (ROSSEY): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04859699).
- REOX IIIndependent statistical analysis of Reoxygenation After Cardiac Arrest II (REOX II Study): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02698826).
- REPAINTIndependent statistical analysis of Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- REPAIRIndependent statistical analysis of REPAIR: Right vEntricular Remodeling in Pulmonary ArterIal hypeRtension: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02310672).
- REPAIRIndependent statistical analysis of REPAIR - transcatheteR rEPair of mitrAl Insufficiency With caRdioband System: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02703311).
- Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap: Complete Statistical AnalysisIndependent statistical analysis of Repair of Soft Tissue Defect of the Finger Using the Heterodigital Neurocutaneous Island Flap: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®): Complete Statistical AnalysisIndependent statistical analysis of REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00127842).
- Reparixin in Pancreatic Islet Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Reparixin in Pancreatic Islet Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01220856).
- Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Reparixin in Prevention of Delayed Graft Function After Kidney Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00248040).
- Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: Complete Statistical AnalysisIndependent statistical analysis of Repeat PET/CT Imaging of Patients With Amyloid 124I-AT-01 to Measure Changes in Organ-specific Amyloid Load: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: Complete Statistical AnalysisIndependent statistical analysis of Repeat Quadratus Lumborum Block to Reduce Opioid Need in Patients After Pancreatic Surgery: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation: Complete Statistical AnalysisIndependent statistical analysis of Repeat Transplantation for Relapsed or Refractory Hematologic Malignancies Following Prior Transplantation: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Repeat-Dose Pharmacokinetics Study of NRL-1 in Epilepsy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02724423).
- Repeatability and Reproducibility of Oxygen Reserve Index (ORi): Complete Statistical AnalysisIndependent statistical analysis of Repeatability and Reproducibility of Oxygen Reserve Index (ORi): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05636098).
- Repeatability in Hyperpolarized 3-Helium With MRI: Complete Statistical AnalysisIndependent statistical analysis of Repeatability in Hyperpolarized 3-Helium With MRI: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03776747).
- Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): Complete Statistical AnalysisIndependent statistical analysis of Repeated Exposure to Eltrombopag in Adults With Idiopathic Thrombocytopenic Purpura (REPEAT): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity: Complete Statistical AnalysisIndependent statistical analysis of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment of Post-Stroke Spasticity: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02268461).
- Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy: Complete Statistical AnalysisIndependent statistical analysis of Repetitive Transcranial Magnetic Stimulation and Acceptance and Commitment Therapy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05427201).